Recent Finacing
Recent Raise
AviadoBio develops AAV-based gene therapies for neurodegenerative disorders, delivering progranulin via targeted thalamic microdosing to achieve widespread CNS expression, with programs for FTD and preclinical ALS.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
